Developer docs
API playgroundTry for free, no card

Search company profiles

Boutique Venture Partners

Full company profile

uuid0006pr2

Namestring
Boutique Venture Partners
Legal namestring
Botique Venture Partners
Websiteurl
boutiquevc.com
Company typeenum
Private
Founded yearint
2020
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital funding, healthcare investments, early-stage investing, life sciences funding, seed and Series A
Industry1 code
1Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryYes
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Venture Capital
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Boutique Venture Partners is an early-stage venture capital firm that invests seed, Series A, and Series B funding in healthcare and life sciences startups. The firm partners with founders in biotech, medtech, digital health, and healthcare-enabling technologies, providing capital, strategic guidance, and access to a network of scientific and clinical advisors from leading academic medical centers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Boutique Venture Partners is a venture capital firm based in Palo Alto, California, specializing in early-stage investments in healthcare and life sciences. The firm does not offer a unified SaaS product but rather provides investment services and manages a portfolio of 16+ portfolio companies across biotechnology, medtech, and digital health sectors including Zeda, miRecule, Delfina Care, Surge Care, Mitra Chem, Genalyte, Handl Health, Smartlens, Fluid AI, QMENTA, Mesentech, Frontier Bio, Filtricine, Docbot, CuraFi, and Esteam AI.

Product and service1 record
1Early-stage healthcare and life sciences venture capital
CategoryVenture Capital / Investment Services
Description

Equity investment service for early-stage (seed, Series A, Series B) companies in healthcare and life sciences. Boutique Venture Partners deploys capital alongside strategic guidance and access to a network of scientific and clinical advisors from Harvard, Stanford, and UCSF.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Lux Capital
TypeBroad incumbent
Description

Sector-focused venture firm investing in science and technology ventures including healthcare and biotech. Comparable sector-specialist thesis but with much larger funds and a broader science/tech mandate.

25AM Ventures
TypeDirect peer
Description

Early-stage life sciences venture capital firm investing in seed and Series A biotech, medtech, and platform companies. Highly comparable to Boutique Venture Partners in stage focus, healthcare specialization, and small-team model.

3ARCH Venture Partners
TypeBroad incumbent
Description

Pioneer science-based venture firm investing early in biotech, advanced materials, and platform technologies from academic institutions. Overlapping sourcing model (academic IP) but substantially larger AUM and broader scope.

4Atypical Ventures
TypeDirect peer
Description

Early-stage venture firm with healthcare and tech exposure. Already co-invests with Boutique Venture Partners (Ventaris Surgical Series A), suggesting directly comparable stage and sector orientation.

5OrbiMed
TypeBroad incumbent
Description

Dedicated healthcare investment firm across venture, growth, credit, and public equities. Overlaps with Boutique Venture Partners in healthcare venture stage but operates at far greater scale and across the full capital stack.

6Versant Ventures
TypeDirect peer
Description

Healthcare-dedicated venture capital firm investing across biotech, medtech, and healthcare services. Comparable vertical specialization and stage breadth, though larger AUM than Boutique Venture Partners.

7Atlas Venture
TypeDirect peer
Description

Early-stage biotech venture capital firm that builds and seeds new therapeutic companies. Directly comparable stage and sector focus, with similar portfolio-construction playbook (formation + early investing in life sciences).

8RA Capital Management
TypeBroad incumbent
Description

Healthcare-focused investment manager with dedicated early-stage venture activity alongside public/private crossover strategies. Comparable healthcare vertical focus, but operates at materially larger scale.

9Section 32
TypeDirect peer
Description

Healthcare-focused venture firm investing at the intersection of technology and biology. Comparable stage focus and healthcare-only mandate, with a similarly compact team profile.

10Digital Health Venture Partners
TypeDirect peer
Description

Early-stage digital health venture capital firm. Already co-invests with Boutique Venture Partners (Handl Health Series A), signaling directly comparable digital health mandate and stage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment27 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Boutique Venture Partners

Healthcare Venture Capitalboutiquevc.com

Boutique Venture Partners firmographics

Firmographics
Name
Boutique Venture Partners
Legal name
Botique Venture Partners
Website
https://boutiquevc.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Boutique Venture Partners industry classification

Industry
Product category
Healthcare Venture Capital
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro primary industry
Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

  • Venture capital funding
  • Healthcare investments
  • Early-stage investing
  • Life sciences funding
  • Seed and Series A

Where Boutique Venture Partners is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Boutique Venture Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels3 records

Boutique Venture Partners product offering

Product offering

Core offering

Boutique Venture Partners is an early-stage venture capital firm that invests seed, Series A, and Series B funding in healthcare and life sciences startups. The firm partners with founders in biotech, medtech, digital health, and healthcare-enabling technologies, providing capital, strategic guidance, and access to a network of scientific and clinical advisors from leading academic medical centers.

Product overview

Boutique Venture Partners is a venture capital firm based in Palo Alto, California, specializing in early-stage investments in healthcare and life sciences. The firm does not offer a unified SaaS product but rather provides investment services and manages a portfolio of 16+ portfolio companies across biotechnology, medtech, and digital health sectors including Zeda, miRecule, Delfina Care, Surge Care, Mitra Chem, Genalyte, Handl Health, Smartlens, Fluid AI, QMENTA, Mesentech, Frontier Bio, Filtricine, Docbot, CuraFi, and Esteam AI.

Differentiator

Problem solved

Functional benefit

Products and services

  • Early-stage healthcare and life sciences venture capital Equity investment service for early-stage (seed, Series A, Series B) companies in healthcare and life sciences. Boutique Venture Partners deploys capital alongside strategic guidance and access to a network of scientific and clinical advisors from Harvard, Stanford, and UCSF.

Companies that use Boutique Venture Partners

Customer profile

Segments1 record

Ideal customer profiles1 record

Boutique Venture Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Boutique Venture Partners partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Boutique Venture Partners competitors and assessment

Company assessment

Broad incumbents

  • Lux Capital: Sector-focused venture firm investing in science and technology ventures including healthcare and biotech. Comparable sector-specialist thesis but with much larger funds and a broader science/tech mandate.
  • ARCH Venture Partners: Pioneer science-based venture firm investing early in biotech, advanced materials, and platform technologies from academic institutions. Overlapping sourcing model (academic IP) but substantially larger AUM and broader scope.
  • OrbiMed: Dedicated healthcare investment firm across venture, growth, credit, and public equities. Overlaps with Boutique Venture Partners in healthcare venture stage but operates at far greater scale and across the full capital stack.
  • RA Capital Management: Healthcare-focused investment manager with dedicated early-stage venture activity alongside public/private crossover strategies. Comparable healthcare vertical focus, but operates at materially larger scale.

Direct peers

  • 5AM Ventures: Early-stage life sciences venture capital firm investing in seed and Series A biotech, medtech, and platform companies. Highly comparable to Boutique Venture Partners in stage focus, healthcare specialization, and small-team model.
  • Atypical Ventures: Early-stage venture firm with healthcare and tech exposure. Already co-invests with Boutique Venture Partners (Ventaris Surgical Series A), suggesting directly comparable stage and sector orientation.
  • Versant Ventures: Healthcare-dedicated venture capital firm investing across biotech, medtech, and healthcare services. Comparable vertical specialization and stage breadth, though larger AUM than Boutique Venture Partners.
  • Atlas Venture: Early-stage biotech venture capital firm that builds and seeds new therapeutic companies. Directly comparable stage and sector focus, with similar portfolio-construction playbook (formation + early investing in life sciences).
  • Section 32: Healthcare-focused venture firm investing at the intersection of technology and biology. Comparable stage focus and healthcare-only mandate, with a similarly compact team profile.
  • Digital Health Venture Partners: Early-stage digital health venture capital firm. Already co-invests with Boutique Venture Partners (Handl Health Series A), signaling directly comparable digital health mandate and stage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Boutique Venture Partners social profiles

Digital presence

Boutique Venture Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Boutique Venture Partners leadership team

Management profile

Number of profiles

Profiles9 records

Boutique Venture Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Boutique Venture Partners M&A and investment

M&A and investment

M&A

Investments27 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boutique Venture Partners

What does Boutique Venture Partners do?

Boutique Venture Partners is an early-stage venture capital firm that invests seed, Series A, and Series B funding in healthcare and life sciences startups. The firm partners with founders in biotech, medtech, digital health, and healthcare-enabling technologies, providing capital, strategic guidance, and access to a network of scientific and clinical advisors from leading academic medical centers.

Is Boutique Venture Partners a public or private company?

Boutique Venture Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Boutique Venture Partners founded?

Boutique Venture Partners was founded in 2020. It employs 1 to 10 people.

Where is Boutique Venture Partners based?

Boutique Venture Partners is headquartered in Palo Alto, United States, in the North America region.

Who are Boutique Venture Partners's main competitors?

Broad incumbents on record are Lux Capital, ARCH Venture Partners, OrbiMed and RA Capital Management. Direct peers are 5AM Ventures, Atypical Ventures, Versant Ventures, Atlas Venture, Section 32 and Digital Health Venture Partners.

Does Boutique Venture Partners have an API?

No public API is recorded for Boutique Venture Partners.

What industry is Boutique Venture Partners in?

Boutique Venture Partners's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Tech TimesGlioblastoma Treatment: UCSF Startup Turns Brain Tumors Into Immune Cell FactoriesKopra Bio, a UCSF startup, closed a $9.1 million seed round to advance its engineered retrovirus KB-516 into a Phase I trial for glioblastoma. The virus turns tumor cells into IL-15 factories, and preclinical data showed durable immune memory in mice. The trial will be conducted in China under a 30-day regulatory pathway.Venture Capital Access OnlineKanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer PatientsKanvas Biosciences raised $48 million in a Series A co-led by DCVC and Lions Capital, with Gates Foundation participating. The funds will advance clinical trials for its lead immuno-oncology drug KAN-001, which targets cancer patients unresponsive to checkpoint inhibitors. The company also plans to launch its own clinical trials and operate a new GMP manufacturing suite.FinSMEsKanvas Biosciences Raises $48M in Series A FundingKanvas Biosciences raised $48M in Series A funding led by DCVC and Lions Capital. The company will use the funds to conduct clinical trials for its immuno-oncology candidate KAN-001 and advance commercial partnerships. The spatial biology company aims to develop live biotherapeutics for microbiome-associated diseases.Wayback MachineOfficial PR Sept 22, 2022Surge, a biotech and medical AI innovator, announced the closing of a $2.6 million funding round co-led by HCVC and Boutique Venture Partners to further develop its machine learning technology for predicting postoperative complications. The company has secured an exclusive license from Stanford University for its patented prediction technology and is conducting clinical studies, including one with Foch Hospital in France. This financing supports Surge's expansion efforts and ongoing research into surgical precision medicine.FinSMEsPrinterPrezz Completes $16M Series A FundingPrinterPrezz, a California-based medifacturing company, completed a $16 million Series A funding round led by D. One Vision Management, with participation from Boutique Venture Partners, Berkeley Catalyst Fund, and strategic investor Solvay Ventures. The company combines additive manufacturing, nanotechnologies, and surgical expertise to develop medical devices from design through FDA approval and volume production.